Atria Investments’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $762K | Buy |
4,416
+1,971
| +81% | +$340K | 0.01% | 1188 |
|
|
2025
Q1 | $381K | Buy |
2,445
+9
| +0.4% | +$1.4K | ﹤0.01% | 1491 |
|
|
2024
Q4 | $335K | Buy |
2,436
+393
| +19% | +$54.1K | ﹤0.01% | 1542 |
|
|
2024
Q3 | $305K | Buy |
2,043
+6
| +0.3% | +$896 | ﹤0.01% | 1615 |
|
|
2024
Q2 | $278K | Buy |
+2,037
| New | +$278K | ﹤0.01% | 1633 |
|
|
2022
Q2 | – | Sell |
-10,674
| Closed | -$1.25M | – | 756 |
|
|
2022
Q1 | $1.25M | Buy |
10,674
+1,098
| +11% | +$129K | 0.02% | 751 |
|
|
2021
Q4 | $1.29M | Buy |
9,576
+88
| +0.9% | +$11.8K | 0.02% | 732 |
|
|
2021
Q3 | $1.51M | Sell |
9,488
-671
| -7% | -$107K | 0.03% | 639 |
|
|
2021
Q2 | $1.34M | Buy |
10,159
+947
| +10% | +$125K | 0.03% | 659 |
|
|
2021
Q1 | $1.19M | Buy |
9,212
+2,371
| +35% | +$306K | 0.03% | 646 |
|
|
2020
Q4 | $1.14M | Buy |
+6,841
| New | +$1.14M | 0.03% | 628 |
|
|
2020
Q2 | – | Sell |
-3,497
| Closed | -$394K | – | 535 |
|
|
2020
Q1 | $394K | Sell |
3,497
-1,812
| -34% | -$204K | 0.03% | 396 |
|
|
2019
Q4 | $739K | Buy |
+5,309
| New | +$739K | 0.02% | 646 |
|
|
2019
Q3 | – | Sell |
-4,466
| Closed | -$509K | – | 858 |
|
|
2019
Q2 | $509K | Buy |
4,466
+417
| +10% | +$47.5K | 0.02% | 574 |
|
|
2019
Q1 | $477K | Sell |
4,049
-673
| -14% | -$79.3K | 0.02% | 544 |
|
|
2018
Q4 | $296K | Sell |
4,722
-117
| -2% | -$7.33K | 0.01% | 656 |
|
|
2018
Q3 | $343K | Sell |
4,839
-128
| -3% | -$9.07K | 0.01% | 719 |
|
|
2018
Q2 | $330K | Buy |
4,967
+1,731
| +53% | +$115K | 0.01% | 712 |
|
|
2018
Q1 | $212K | Buy |
+3,236
| New | +$212K | 0.01% | 795 |
|